These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 18756652)

  • 1. Update on the treatment of tuberculosis.
    Inge LD; Wilson JW
    Am Fam Physician; 2008 Aug; 78(4):457-65. PubMed ID: 18756652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient management of tuberculosis.
    McColloster P; Neff NE
    Am Fam Physician; 1996 Apr; 53(5):1579-94. PubMed ID: 8623687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
    Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of latent tuberculosis infection: renewed opportunity for tuberculosis control.
    Cohn DL
    Clin Infect Dis; 2000 Jul; 31(1):120-4. PubMed ID: 10913407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
    Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
    Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
    Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and management of latent tuberculosis infection.
    Hauck FR; Neese BH; Panchal AS; El-Amin W
    Am Fam Physician; 2009 May; 79(10):879-86. PubMed ID: 19496388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis in the 1990's: resurgence, regimens, and resources.
    Pust RE
    South Med J; 1992 Jun; 85(6):584-93. PubMed ID: 1604386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
    Hoopes AJ; Kammerer JS; Harrington TA; Ijaz K; Armstrong LR
    Arch Intern Med; 2008 Oct; 168(18):1984-92. PubMed ID: 18852399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Latent tuberculosis infection: diagnosis and treatment].
    Bendayan D; Raz M; Kramer MR
    Harefuah; 2002 Mar; 141(3):233-6, 316. PubMed ID: 11944212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States.
    LoBue PA; Enarson DA; Thoen TC
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1226-32. PubMed ID: 20843412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDC recommends four-drug treatment of tuberculosis in multidrug-resistant era.
    Am Fam Physician; 1993 Sep; 48(4):671-2. PubMed ID: 8397483
    [No Abstract]   [Full Text] [Related]  

  • 15. 4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: a meta-analysis and cost-effectiveness study that focuses on compliance and liver toxicity.
    Ziakas PD; Mylonakis E
    Clin Infect Dis; 2009 Dec; 49(12):1883-9. PubMed ID: 19911936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Completing tuberculosis prophylaxis in jail: targeting treatment and comparison of rifampin/pyrazinamide with isoniazid regimens.
    Lincoln T; Brannan GL; Lynch V; Conklin TJ; Clancey T; Rose DN; Tuthill RJ
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):306-11. PubMed ID: 15139468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches to the treatment of latent tuberculosis.
    Sterling TR
    Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent tuberculosis in pregnancy: screening and treatment.
    Bergeron KG; Bonebrake RG; Allen C; Gray CJ
    Curr Womens Health Rep; 2003 Aug; 3(4):303-8. PubMed ID: 12844453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and prevention of tuberculosis in HIV-infected persons.
    Cohn DL
    Infect Dis Clin North Am; 1994 Jun; 8(2):399-412. PubMed ID: 8089467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.